solriamfetol
-
Sleep Health
New Clinical Trial Demonstrates Solriamfetol Enhances Alertness and Occupational Safety for Early Morning Shift Workers
While the traditional 9-to-5 workday remains the standard for many, a significant and growing portion of the global workforce operates…
Read More » -
Sleep Health
Clinical Trial Finds Solriamfetol Significantly Improves Alertness and Performance for Early Morning Shift Workers Facing Shift Work Disorder
A groundbreaking clinical trial led by researchers at Mass General Brigham has revealed that solriamfetol, a wake-promoting medication currently used…
Read More » -
Sleep Health
Clinical Trial Finds Solriamfetol Significantly Improves Alertness and Performance in Early Morning Shift Workers Suffering from Shift Work Disorder
The landscape of modern labor is increasingly defined by non-traditional hours, with approximately one-quarter of the global workforce operating outside…
Read More » -
Sleep Health
Clinical Trial Demonstrates Effectiveness of Solriamfetol in Improving Alertness for Early Morning Shift Workers
The biological cost of the modern 24-hour economy is often paid by those who rise while the rest of the…
Read More » -
Sleep Health
Clinical Trial at Mass General Brigham Reveals Solriamfetol Effectively Combats Fatigue in Early Morning Shift Workers with Shift Work Disorder
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication currently used…
Read More » -
Sleep Health
Solriamfetol Shows Promise in Enhancing Alertness and Safety for Early Morning Shift Workers Suffering from Shift Work Disorder
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that the wake-promoting medication solriamfetol, marketed under…
Read More » -
Sleep Health
Solriamfetol Shows Promise in Improving Alertness for Early Morning Shift Workers Facing Shift Work Disorder
The landscape of modern labor is increasingly defined by non-traditional hours, with approximately 20% to 25% of the global workforce…
Read More » -
Sleep Health
Clinical Trial Finds Solriamfetol Effective in Reducing Excessive Sleepiness Among Early Morning Shift Workers
Researchers at Mass General Brigham have released the results of a groundbreaking clinical trial demonstrating that solriamfetol, a wake-promoting medication…
Read More » -
Sleep Health
Solriamfetol Shows Significant Promise in Treating Shift Work Disorder Among Early Morning Workers in New Clinical Trial
A groundbreaking clinical trial led by researchers at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication, significantly improves…
Read More » -
Sleep Health
Breakthrough Clinical Trial Finds Solriamfetol Enhances Alertness and Safety for Early Morning Shift Workers Facing Shift Work Disorder
A pioneering clinical trial led by investigators at Mass General Brigham has demonstrated that solriamfetol, a wake-promoting medication currently marketed…
Read More »
